Scientific support for private stem cell storage
04 Junio 2010 - 1:00AM
RNS Non-Regulatory
TIDMCRYO
Cryo-Save Group NV
04 June 2010
?
4 June 2010
Cryo-Save Group N.V.
Scientists give the go-ahead for private storage of stem cells from umbilical
cord blood
Four world-renowned stem cell experts* have recently given their full support to
private cordblood banking. The four scientists supported the foundation of the
"Family Cord Blood Bank" which has just been established in the US by CORD:USE.
Cryo-Save (Euronext/AIM: CRYO), the largest stem cell bank in Europe, is very
pleased with this positive development.
Arnoud van Tulder, Cryosave CEO said
"We expect that the merit of private storage of stem cells will also increase in
Europe and that the sometimes unreasonable arguments, which prevent people from
storing stem cells in a number of countries, will disappear. Combined storage
seems to be the way of the future".
What is the merit of umbilical cord blood?
Umbilical cord blood contains very valuable cells; stem cells which can multiply
and grow into cells which can cure serious and sometimes deadly diseases. They
are used to combat more than 70 different diseases and research into new
applications is continuously increasing; at present, more than 3,000 clinical
studies are in progress**. The blood and the stem cells are analyzed and
processed using advanced technology and subsequently stored in the gas phase of
liquid nitrogen. When needed, the cells can be used immediately.
Private versus public storage?
As a parent, you can have the umbilical cord blood with the stem cells of your
child stored in the private or family blood bank. The stem cells are then
available for later use and guarantee an exact match for the child concerned,
and 25% chance that they are also an exact match for a brother or sister.
Worldwide, hundreds of thousands of parents already decided to store the stem
cells from the umbilical cord blood of their children in a private bank.
When the choice is public storage, the parents decide to make the stem cells
available to others. The cells can then be utilized to save the life of another,
unknown person, who shows a match with the donor blood. However, the donor
parents do not have any guarantee that the stem cells remain available for their
own child as well. In addition, it turns out that only 30 to 50% of all
donations are indeed stored. The rest is destroyed. You will only get the
guarantee that the stem cells are available if your child needs them by storing
in a private or family bank.
Cryo-Save goes for combined storage
With more than 130,000 samples stored and activities in more than 38 countries,
Cryo-Save is the largest stem cell bank in Europe.
The stem cells are taken from the umbilical cord and umbilical tissue. In Italy,
Cryo-Save offers combined storage for both private as well as public use. This
offers the guarantee that the blood is available for one's own child if it is
ever needed, but is also available to help others. Pending approval of the
authorities, Cryo-Save plans to introduce this "best-of-both worlds"
combined-storage service in other countries as well.
Cryo-Save (www.cryo-save.com)
With more than 130,000 samples stored, Cryo-Save Group, with their head office
in Zutphen, is the largest stem cell bank for stem cells from umbilical cord
blood and umbilical cords in Europe and one of the fastest-growing in the world.
Cryo-Save not only stores stem cells from the blood of the umbilical cord but
distinguishes itself from its competitors in Europe, the United States and Asia
by also storing a part of the umbilical cord itself which contains valuable
mesenchymal stem cells (MSCs). Since May 21 of this year, Cryo-Save also stores
MSCs from the fat tissue of adults (Cryo-Lip , http://www.cryo-lip.com).
Driven by an international strategy, Cryo-Save is currently located in 38
countries on three continents. The enterprise has highly advanced technological
laboratories and storage facilities in Belgium, Germany, Dubai, India and France
(in construction).
Note to editors
** www.clinicaltrials.gov/ct2/results?term=stem+cell
* The scientific experts behind the public blood banks now also support the
merit of private storage. Prof. Dr. Hal Broxmeyer, Prof. Dr. John Wagner, Prof.
Dr. Joanna Kurtzberg and Prof. Dr. Elianne Gluckman are the main references
worldwide as far as stem cell transplantations from umbilical cord blood are
concerned. During the past 20 years, these stem cell experts have performed
thousands of transplantations with stem cells from umbilical cord blood and have
hundreds of publications to their credit. (More info at http://www.corduse.com).
Prof. Hal Broxmeyer
Professor Hal Broxmeyer is the founder of the public bank, CORD:USE Stem Cell
Blood Bank, (Florida, USA)and president of the "American Society of Hematology"
(16,000 members in 97 countries). He is internationally recognized as the
founder of the field of stem cell transplantation using cells from umbilical
cord blood. He was involved with the planning and coordination of the first
successfully performed transplantation in 1988.
Prof. John Wagner
Professor John Wagner is the director of the "Stem Cell Institute of the
University of Minnesota". He and his team were the first to use stem cells from
the umbilical cord for the treatment of leukemia.
Prof. Joanna Kurtzberg
Professor Joanna Kurzberg is the director of "Duke University's Pediatric and
Marrow Transplant Program" and performed the first ever successful
transplantation with allogenous stem cells from umbilical cord blood in 1993.
Prof. Elianne Gluckman
Professor Elianne Gluckman is connected to the "Hematology University Paris VII"
and president of the European School of Hematology. In 1988, she performed the
first ever stem cell transplantation.
http://www.corduse.com/public-cord-blood-bank/press_room/index.php?page=news&id
25&act=view
For more information: Cryo-Save Group +31(0)575-548-998, Arnoud van Tulder, CEO,
Marc Waeterschoot, Executive Director
For more information about this press release, surf to
http://www.cryo-savegroup.com/investor_news.html and
http://www.cryo-savegroup.com/company_news.html
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRABRGDLIGGBGGX
Cryo-Save (LSE:CRYO)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Cryo-Save (LSE:CRYO)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Cryo-Save (London Stock Exchange): 0 recent articles
Más de Cryo-Save Artículos de Noticias